GLOB

GLOB

USD

Globant S.A. Common Shares

$62.815+0.795 (1.282%)

Real-time Price

Technology
Information Technology Services
Luxembourg

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$62.020

High

$62.880

Low

$60.675

Volume

1.00M

Company Fundamentals

Market Cap

2.8B

Industry

Information Technology Services

Country

Luxembourg

Trading Stats

Avg Volume

1.58M

Exchange

NYQ

Currency

USD

52-Week Range

Low $54.36Current $62.815High $238.32

Related News

PR Newswire

Globant to Announce Third Quarter 2025 Financial Results on November 13th

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will...

View more
Globant to Announce Third Quarter 2025 Financial Results on November 13th
PR Newswire

Globant to Announce Third Quarter 2025 Financial Results on November 13th

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will...

View more
Globant to Announce Third Quarter 2025 Financial Results on November 13th
Analyst Upgrades

Citigroup Initiates Coverage On Globant with Neutral Rating, Announces Price Target of $67

Citigroup analyst Bryan Keane initiates coverage on Globant with a Neutral rating and announces Price Target of $67.

View more
Citigroup Initiates Coverage On Globant with Neutral Rating, Announces Price Target of $67
Analyst Upgrades

Wells Fargo Initiates Coverage On Globant with Equal-Weight Rating, Announces Price Target of $61

Wells Fargo analyst Jason Kupferberg initiates coverage on Globant with a Equal-Weight rating and announces Price Target of $61.

View more
Wells Fargo Initiates Coverage On Globant with Equal-Weight Rating, Announces Price Target of $61
PR Newswire

MIT Technology Review Insights and Globant Report: Three quarters of global pharma organizations are piloting or deploying agentic AI

Globant (NYSE: GLOB), a digitally native company that helps organizations thrive in a digital and AI-powered future, has partnered with MIT...

View more
MIT Technology Review Insights and Globant Report: Three quarters of global pharma organizations are piloting or deploying agentic AI